ChipBull Biotech Co., Ltd.
芯牛生物
ChipBull Biotech Co., Ltd.
Biotech/Healthcare
Xinniu Biotech has closed an angel round of over RMB 10 million, which will fund the development of its cancer vaccine and oncolytic virus pipelines, with the potential to benefit patients with solid tumors.
Latest round: Angel (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-22
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.